# A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.

> **NCT03281876** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 606 (actual)

## Conditions studied

- Respiratory Disorders

## Interventions

- **BIOLOGICAL:** NTHi Mcat investigational vaccine (GSK3277511A)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03281876
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-27
- **Primary completion:** 2020-03-26
- **Final completion:** 2020-03-26
- **Target enrollment:** 606 (ACTUAL)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03281876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03281876, "A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03281876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*